Metraipolis › archive › dc_057b04e87b06

Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy — Europe PMC PMID:42598380

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42598380
DOI
10.1021/acsomega.6c00948
License (as archived)
solo-consultazione
Archived
2026-10-18T13:58:50.284Z
SHA-256 of the archived text
9ae848edf3c2342a28e5d6db2a83e2f64a7650eee3340c3012037e1360d49ad5
Stable URL of this page
https://metraipolis.com/documento/dc_057b04e87b06

How to cite

Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy — Europe PMC PMID:42598380 — Europe PMC (en), https://europepmc.org/article/MED/42598380 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_057b04e87b06 (Metraipolis archive dc_057b04e87b06, sha256 9ae848edf3c2342a28e5d6db2a83e2f64a7650eee3340c3012037e1360d49ad5)
BibTeX
@misc{dc057b04e87b06,
  title = {Feasibility of Polylactic Acid-Polycaprolactone-Blended Microspheres in Transarterial Embolization Therapy — Europe PMC PMID:42598380},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42598380},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_057b04e87b06; sha256 9ae848edf3c2342a28e5d6db2a83e2f64a7650eee3340c3012037e1360d49ad5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42598380. Agents can read the archived copy with the MCP tool read_document.